Published in Obesity and Diabetes Week, October 3rd, 2005
This change marks a significant shift away from trans fatty acids, unsaturated fatty acids created during the hydrogenation process, which have been proven to increase low-density lipoproteins, also known as "bad cholesterol."
"As more information becomes available on the risks posed by trans fatty acids, Sodexho felt we owed it to our customers to find a way to serve them...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.